Free Trial
NYSEMKT:PHGE

BiomX (PHGE) Stock Price, News & Analysis

BiomX logo
$0.73
0.00 (0.00%)
(As of 11/4/2024 ET)

About BiomX Stock (NYSEMKT:PHGE)

Key Stats

Today's Range
$0.62
$0.83
50-Day Range
$0.73
$1.40
52-Week Range
N/A
Volume
121,114 shs
Average Volume
68,601 shs
Market Capitalization
$13.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.50
Consensus Rating
Buy

Company Overview

BiomX Inc., a clinical-stage biopharmaceutical company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria associated with chronic disease. It is developing BX211, a phage therapy, which is in phase 2 clinical study for the treatment of diabetic foot osteomyelitis. The company's product pipeline also includes BX004, a phage therapy for cystic fibrosis patients with chronic pulmonary infections caused by Pseudomonas aeruginosa that is in Phase 1b/2a clinical trials. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.

Receive PHGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BiomX and its competitors with MarketBeat's FREE daily newsletter.

PHGE Stock News Headlines

BiomX Announces a Mandatory Unit Separation
Blackrock’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
PHGE-U,0P0001F68H,0 (PHGE-U)
BiomX Inc. (PHGE) Q2 2024 Earnings Call Transcript
VinFast Returns to Canadian National Exhibition 2024
See More Headlines

PHGE Stock Analysis - Frequently Asked Questions

BiomX's stock was trading at $2.80 on January 1st, 2024. Since then, PHGE stock has decreased by 74.0% and is now trading at $0.7285.
View the best growth stocks for 2024 here
.

BiomX Inc. (NYSEMKT:PHGE) posted its earnings results on Monday, May, 15th. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of ($1.80) by $0.20.

BiomX shares reverse split on the morning of Monday, August 26th 2024. The 1-10 reverse split was announced on Thursday, August 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 23rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of PHGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that BiomX investors own include Predictive Oncology (POAI), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), NVIDIA (NVDA), Zomedica (ZOM), Insulet (PODD) and Ford Motor (F).

Company Calendar

Last Earnings
5/15/2023
Today
11/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSEMKT:PHGE
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$22.50
High Stock Price Target
$25.00
Low Stock Price Target
$20.00
Potential Upside/Downside
+2,988.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-28,320,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.70 per share

Miscellaneous

Free Float
44,044,000
Market Cap
$13.04 million
Optionable
Not Optionable
Beta
1.32
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NYSEMKT:PHGE) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners